ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 53

$918K Total Retail Price of All Prescriptions

Rank: 14 out of 53

183 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 9,808 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

37% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

72 is the average number of prescriptions (including refills) per patient, compared to an average of 31.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LISINOPRIL 650 479 1 2
NAMENDA 528 502 2 11
LEVOXYL 424 344 3 131
LANTUS 370 277 4 25
SIMVASTATIN 359 286 5 4
OMEPRAZOLE 346 270 6 9
POLYETHYLENE GLYCOL 3350 342 281 7 34
MIRTAZAPINE 327 282 8 14
DONEPEZIL HCL 325 273 9 10
CITALOPRAM HBR 324 242 10 13
FUROSEMIDE 305 245 11 3
CARVEDILOL 289 192 12 21
AMLODIPINE BESYLATE 272 224 13 5
COUMADIN 248 191 14 117
TRAZODONE HCL 243 169 15 16
METOPROLOL TARTRATE 229 206 16 8
KLOR-CON M20 229 133 16 69
GABAPENTIN 207 120 18 17
ADVAIR DISKUS 197 158 19 61
CYMBALTA 185 90 20 30
SERTRALINE HCL 165 139 21 19
NOVOLOG 157 109 22 43
BACLOFEN 155 30 23 68
LEVETIRACETAM 152 78 24 51
QUETIAPINE FUMARATE 147 135 25 37
METFORMIN HCL 146 45 26 18
RANITIDINE HCL 141 112 27 35
GLIPIZIDE 136 90 28 45
JANUVIA 126 67 29 87
DIVALPROEX SODIUM 117 49 30 33
SPIRIVA 116 97 31 78
ATORVASTATIN CALCIUM 113 81 32 28
LOSARTAN POTASSIUM 109 104 33 29
CARBIDOPA-LEVODOPA 108 88 34 47
SEROQUEL 104 88 35 77
FLUTICASONE PROPIONATE 100 82 36 38
KLOR-CON M10 93 61 37 130
METOPROLOL SUCCINATE 92 78 38 22
HUMALOG 92 81 38 183
NYSTOP 90 70 40 111
NIASPAN 86 55 41 166
SPIRONOLACTONE 85 46 42 56
TAMSULOSIN HCL 82 58 43 32
CLOPIDOGREL 79 71 44 40
DIVALPROEX SODIUM ER 79 58 44 63
LUMIGAN 79 70 44 231
FAMOTIDINE 76 57 47 46
CIPROFLOXACIN HCL 75 54 48 66
LIPITOR 74 52 49 180
HYDROCHLOROTHIAZIDE 72 47 50 20
LEVOFLOXACIN 72 53 50 84
DIOVAN 72 61 50 71
ISOSORBIDE MONONITRATE ER 72 60 50 42
NEXIUM 67 48 54 52
DILANTIN 67 65 54 197
PENTOXIFYLLINE 67 50 54 235
VENLAFAXINE HCL ER 67 32 54 93
PLAVIX 64 57 58 61
PANTOPRAZOLE SODIUM 64 63 58 44
RISPERIDONE 60 55 60 24
HYDRALAZINE HCL 58 37 61 57
PREDNISONE 54 42 62 49
ABILIFY 52 19 63 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.